AMY LUCHSINGER: Open Payments
NPI 1285067637 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 28 payments from 11 companies in 2025. Trend: 2023 $579 · 2024 $450 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $146 |
| Boston Scientific Corporation | 1 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Corcept Therapeutics | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Abbott Laboratories | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Insulet Corporation | 1 | $15 |
Products named: OTEZLA, WATCHMAN, MOUNJARO, Korlym, REXULTI, VOQUEZNA, FREESTYLE LIBRE 3, GARDASIL 9.
Industry payments across NY — which companies pay providers there.
